Anti-GD2 antibody and Vorinostat immunocombination therapy is highly effective in an aggressive orthotopic neuroblastoma model

Neuroblastoma is a childhood malignancy and in the majority of patients, the primary tumor arises in one of the adrenal glands. Neuroblastoma cells highly express the disialoganglioside GD2, which is the primary target for the development of neuroblastoma immunotherapy. Anti-GD2 mAbs have shown clin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: van den Bijgaart, Renske J. E., Kroesen, Michiel, Brok, Ingrid C., Reijnen, Daphne, Wassink, Melissa, Boon, Louis, Hoogerbrugge, Peter M., Adema, Gosse J
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2020
Assuntos:
Brief Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7781842/
https://ncbi.nlm.nih.gov/pubmed/33457098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2020.1817653
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados